S065 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
DESCRIPTION
"This session will examine the data and provide an evidenced based discussion about best cost effective practices to care for patients with photoaging, acne, psoriasis, HS, as well as hair and nail disease.
This session will provide an opportunity to review and apply some time-honored strategies, as well as a few new ones, to the factors that make our lives feel out of control. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org"
LEARNING OBJECTIVES
Assess cost effective care of various skin diseases and conditions including photoaging, acne, hair and nail disease, among others.
Examine evidence that drives decision making for skin disease such as psoriasis and HS.
SCHEDULE
1:00 PM
Introduction
Scott Elman, MD, FAAD
1:05 PM
Evidenced based care of alopecia areata
Arash Mostaghimi, MD, MPH, FAAD
1:35 PM
Evidenced based care of CTCL
Xiaolong Alan Zhou, MD, MSc, FAAD
2:05 PM
Evidenced based care of psoriasis
Zenas Yiu, MBChB, PhD, MSc, IFAAD
2:35 PM
Evidenced based care of acne
Jonette Elizabeth Keri, MD, PhD, FAAD
3:05 PM
Evidenced base care of photoaging
Shasa Hu, MD, FAAD
3:35 PM
Evidenced base care of urticaria
Scott Elman, MD, FAAD
DIRECTOR
Scott Elman, MD, FAAD
SPEAKERS
Shasa Hu, MD, FAAD
Jonette Elizabeth Keri, MD, PhD, FAAD
Arash Mostaghimi, MD, MPH, FAAD
Zenas Yiu, MBChB, PhD, MSc, IFAAD
Xiaolong Alan Zhou, MD, MSc, FAAD
HANDOUTS
DISCLOSURES
Scott Elman, MD, FAAD
Biogen – Consultant(Fees); Blueprint Medicines – Advisory Board(Fees); EMD Serono – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding);
Shasa Hu, MD, FAAD
BPG bio – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Consultant(Honoraria); Swiss American – Consultant(Honoraria);
Jonette Elizabeth Keri, MD, PhD, FAAD
Almirall – Consultant(Fees); Galderma Mexico – Speaker(Honoraria); Galderma USA – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Primus Pharmaceuticals – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Arash Mostaghimi, MD, MPH, FAAD
AbbVie – Consultant(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Equillium, Inc. – Consultant(Fees); Hims – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Indomo – Consultant (1099 relationship)(Fees); Legacy Healthcare – Consultant (1099 relationship)(Fees); Olaplex – Advisory Board(Fees); Pelage Pharmaceuticals – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Consultant(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);
Zenas Yiu, MBChB, PhD, MSc, IFAAD
No financial relationships exist with ineligible companies.
Xiaolong Alan Zhou, MD, MSc, FAAD
Kyowa Kirin – Consultant (1099 relationship)(Fees); Therakos, Inc. – Consultant (1099 relationship)(Fees);